What is HumanFirst?
HumanFirst operates at the intersection of clinical research and operational technology, providing the essential infrastructure required to support decentralized clinical trials and home-based care delivery. By streamlining the complex logistics associated with remote patient monitoring and data collection, the company addresses systemic inefficiencies that have historically hindered medical innovation. Its platform serves as a foundational layer for life sciences organizations, enabling them to transition away from traditional, site-centric trial models toward more flexible, patient-centric approaches that reduce the burden on participants and improve data integrity.
How much funding has HumanFirst raised?
HumanFirst has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2021): $12M with participation from Lux Capital, Boost VC, Maverick Ventures, villageglobal.com, SV Angel, and Arkitekt Ventures
Key Investors in HumanFirst
Lux Capital
Lux Capital is a New York based venture capital firm that raises dedicated funds to invest in earlystage and growthstage companies at the intersection of science and technology, backing founders in frontier areas such as AI, robotics, space, defense, biotechnology, and advanced materials from seed through IPO or acquisition.
Boost VC
Boost VC is a leading investor in deep tech, focusing on emerging and frontier categories. They provide funding primarily through Pre-Seed rounds with investments averaging $500k, as well as offering a $50k Fellowship check for early-stage startups.
Village Global
Village Global VC is an early-stage venture capital firm that supports startups with funding, mentorship, and access to a network of successful entrepreneurs and investors, focusing on resourceful founders across various sectors.
What's next for HumanFirst?
With this major strategic investment, HumanFirst is well-positioned to expand its footprint in the enterprise healthtech sector. The company's roadmap likely involves deepening its integration with existing clinical trial workflows and enhancing its data analytics capabilities to support more complex, multi-site decentralized studies. As the industry continues to embrace remote-first methodologies, HumanFirst is poised to capture significant market share by providing the robust, scalable infrastructure necessary to sustain the next generation of medical research and distributed healthcare delivery.
See full HumanFirst company page
